Rapamycin Treatment for ALS

Clinical trial NCT03359538 · COMPLETED

Trial details

NCT number: NCT03359538
Sponsor: Azienda Ospedaliero-Universitaria di Modena
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-09-19
Primary completion: 2020-12-15
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.